PharmaZen Limited (in Receivership) - Opportunity to acquire business and assets

Opportunity to acquire the business and/or assets of PharmaZen Limited (In Receivership) ("PharmaZen").

PharmaZen Limited was placed into receivership on 30 March 2026, with Malcolm Hollis and Richard Nacey of Teneo Financial Advisory New Zealand Limited appointed as Receivers.

Headquartered in Christchurch, PharmaZen specialises in transforming sustainably sourced raw materials from New Zealand, Australia and Antarctica, into high-quality nutraceutical ingredients for dietary supplements and functional foods.

PharmaZen’s diverse portfolio includes marine oils and proteins, collagen, calcium, and freeze-dried glandular products derived from bovine, ovine, and porcine sources, complemented by a growing range of botanical extracts and premium pet treats/supplements. These ingredients are supplied to global supplement brands and used in PharmaZen’s own branded line.

The Receivers are seeking expressions of interest in the business as a going concern and/or the assets of the Company.

The Company’s assets include, among other things:
• Specialised manufacturing, extraction and freeze drying plant and equipment
• Intellectual property, formulations, know how, trademarks and brands
• Regulatory approvals, certifications and quality systems
• Inventory and work in progress
• Leased and owned facilities and associated infrastructure

Further information will be made available to qualified parties who execute a confidentiality agreement.

Parties with a genuine interest in receiving further information are invited to register their interest with the Receivers no later than 30 April 2026 to receive an Information Memorandum and participate of the sale process.

Please contact Chris Whiteside on 021 893 901 or chris.whiteside@teneo.com (preferred).